Skip to content
healthcare.dev

ascorbic acid 113 MG / beta carotene 7160 MG / cuprous oxide 0.4 MG / dl-alpha tocopheryl acetate 100 UNT / zinc oxide 17.4 MG Oral Tablet [PreserVision]

RxNorm concept 891815, branded drug (sbd).

RxCUI
891815
Term type
Branded drug (SBD)
Status
Active
Request
curl https://api.healthcare.dev/v1/drugs/rxnorm/891815 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

Other names

PreserVision (ascorbic acid 113 MG / beta carotene 7160 MG / cuprous oxide 0.4 MG / dl-alpha tocopheryl acetate 100 UNT / zinc oxide 17.4 MG) Oral Tablet; vit-C 113 MG / Beta Carotene 7160 MG / cuprous oxide 0.4 MG / dl-alpha tocopheryl acetate 100 UNT / ZNO 17.4 MG Oral Tablet [PreserVision]; vitamin C 113 MG / Beta Carotene 7160 MG / cuprous oxide 0.4 MG / dl-alpha tocopheryl acetate 100 UNT / ZNO 17.4 MG Oral Tablet [PreserVision]

Related concepts

Linked data

NDCs

  • 24208043262
  • 24208043272

NDC-11s RxNorm links to this concept; linked ones open their FDA product.

Use it

Look up 891815 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/rxnorm/891815 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up RxNorm concept 891815. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.